1. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol. 2004; 123:455–457.
Article
2. Manolache L, Petrescu-Seceleanu D, Benea V. Alopecia areata and relationship with stressful events in children. J Eur Acad Dermatol Venereol. 2009; 23:107–109.
Article
3. Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, Hwang CY, et al. Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study. Br J Dermatol. 2012; 166:525–531.
Article
4. Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol. 2007; 21:921–928.
Article
5. Atefi N, Soltani-Arabshahi R, Afkham-Ebrahimi A. Stressful life events and diffuse unexplained hair loss in women: a case-control study. Dermatology. 2006; 213:44–45.
Article
6. Arck PC, Handjiski B, Hagen E, Joachim R, Klapp BF, Paus R. Indications for a 'brain-hair follicle axis (BHA)': inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J. 2001; 15:2536–2538.
Article
7. Arck PC, Slominski A, Theoharides TC, Peters EM, Paus R. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol. 2006; 126:1697–1704.
Article
8. Arck PC, Handjiski B, Kuhlmei A, Peters EM, Knackstedt M, Peter A, et al. Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition. J Mol Med (Berl). 2005; 83:386–396.
Article
9. Theoharides TC, Spanos C, Pang X, Alferes L, Ligris K, Letourneau R, et al. Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology. 1995; 136:5745–5750.
Article
10. Esposito P, Chandler N, Kandere K, Basu S, Jacobson S, Connolly R, et al. Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther. 2002; 303:1061–1066.
Article
11. Chebotaev DV, Yemelyanov AY, Lavker RM, Budunova IV. Epithelial cells in the hair follicle bulge do not contribute to epidermal regeneration after glucocorticoid-induced cutaneous atrophy. J Invest Dermatol. 2007; 127:2749–2758.
Article
12. Choi SJ, Cho AR, Jo SJ, Hwang ST, Kim KH, Kwon OS. Effects of glucocorticoid on human dermal papilla cells in vitro. J Steroid Biochem Mol Biol. 2013; 135:24–29.
Article
13. Méndez-Cuesta LA, Márquez-Valadez B, Pérez-De La Cruz V, Escobar-Briones C, Galván-Arzate S, Alvarez-Ruiz Y, et al. Diazepam blocks striatal lipid peroxidation and improves stereotyped activity in a rat model of acute stress. Basic Clin Pharmacol Toxicol. 2011; 109:350–356.
Article
14. Shin H, Cho AR, Kim DY, Munkhbayer S, Choi SJ, Jang S, et al. Enhancement of human hair Growth using ecklonia cava polyphenols. Ann Dermatol. 2016; 28:15–21.
Article
15. Shin H, Yoo HG, Inui S, Itami S, Kim IG, Cho AR, et al. Induction of transforming growth factor-beta 1 by androgen is mediated by reactive oxygen species in hair follicle dermal papilla cells. BMB Rep. 2013; 46:460–464.
Article
16. Yoon SY, Yoon JS, Jo SJ, Shin CY, Shin JY, Kim JI, et al. A role of placental growth factor in hair growth. J Dermatol Sci. 2014; 74:125–134.
Article
17. Jo SJ, Choi SJ, Yoon SY, Lee JY, Park WS, Park PJ, et al. Valproic acid promotes human hair growth in in vitro culture model. J Dermatol Sci. 2013; 72:16–24.
Article
18. Kwon OS, Pyo HK, Oh YJ, Han JH, Lee SR, Chung JH, et al. Promotive effect of minoxidil combined with all-trans retinoic acid (tretinoin) on human hair growth in vitro. J Korean Med Sci. 2007; 22:283–289.
Article
19. Liu N, Wang LH, Guo LL, Wang GQ, Zhou XP, Jiang Y, et al. Chronic restraint stress inhibits hair growth via substance P mediated by reactive oxygen species in mice. PLoS One. 2013; 8:e61574.
Article
20. Ghisleni G, Capiotti KM, Da Silva RS, Oses JP, Piato ÂL, Soares V, et al. The role of CRH in behavioral responses to acute restraint stress in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 36:176–182.
Article
21. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997; 77:1033–1079.
Article
22. Prignano F, Lotti T, Spallanzani A, Berti S, de Giorgi V, Moretti S. Sequential effects of photodynamic treatment of basal cell carcinoma. J Cutan Pathol. 2009; 36:409–416.
Article
23. Yoshikawa H, Tasaka K. Suppression of mast cell activation by glucocorticoid. Arch Immunol Ther Exp (Warsz). 2000; 48:487–495.
Article
24. Ito N, Sugawara K, Bodó E, Takigawa M, van Beek N, Ito T, et al. Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. J Invest Dermatol. 2010; 130:995–1004.
Article
25. Peters EM, Arck PC, Paus R. Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp Dermatol. 2006; 15:1–13.
Article
26. Ilves T, Harvima IT. Decrease in chymase activity is associated with increase in IL-6 expression in mast cells in atopic dermatitis. Acta Derm Venereol. 2015; 95:411–416.
Article
27. Kwack MH, Ahn JS, Kim MK, Kim JC, Sung YK. Dihydrotestosterone-inducible IL-6 inhibits elongation of human hair shafts by suppressing matrix cell proliferation and promotes regression of hair follicles in mice. J Invest Dermatol. 2012; 132:43–49.
Article
28. Hoffmann R, Wenzel E, Huth A, van der Steen P, Schäufele M, Henninger HP, et al. Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol. 1994; 103:530–533.
Article
29. Swolin-Eide D, Ohlsson C. Effects of cortisol on the expression of interleukin-6 and interleukin-1 beta in human osteoblast-like cells. J Endocrinol. 1998; 156:107–114.
Article